Conclusions In male infertility treatments based on antioxidants, RS poses a paradoxical risk
Each of the lawsuits raises similar allegations, indicating that the drug makers knew or should have known about the potential gastroparesis side effects, but placed a desire for profits above consumer safety, by withholding critical warnings and safety information from consumers and the medical community
Microdose GLP-1 Protocol at $129/month flat ($1,548/year) saves roughly $2,016/year against Henry
While there were initial concerns about suicidal ideation, recent reviews by agencies like the FDA have indicated no increased risk associated with these medications [c125]
Real-world data with behavioural support Second Natures peer-reviewed research, published in JMIR Formative Research (2025), showed that semaglutide, combined with registered dietitian support and a structured behaviour change programme, produced an average 19.1% weight loss at 12 months, with 77.7% of participants achieving at least 10% weight loss
Most people find the end-of-week dip becomes less noticeable after two to three months of treatment for exactly this reason